Science

The Unicity Difference: Research and Development

Quality and safety are the hallmarks of Unicity products, which are manufactured in FDA-approved facilities under stringent good manufacturing practices (GMP), as defined by government regulatory procedures. The team of scientists at Unicity works in partnership with the scientists and technicians at our manufacturing plants to ensure that the products quality is unequivocal. Proof of efficacy of an increasing number of our products is backed by clinical studies, which are published in peer-reviewed medical and scientific journals. If primary research on a product is not yet available, the product is designed based on clinical research on individual ingredients. Where applicable, patented and standardized ingredients are used in the formulating and production processes. We do our best to use only natural ingredients and avoid artificial colorings and flavorings. All finished products are sampled and analyzed to certify compliance to label claims.

Bios Life has had numerous clinical studies conducted at several of the most prestigious hospitals and universities in the US and globally including the Cleveland Clinic, which is recognized at the #1 Heart Institute in the US. We value our international research network, comprised of universities, research institutes, and hospitals, that sets us apart in the nutritional field today, and that provides us access to the latest discoveries in the nutritional sciences.

Bios Life is listed in the PDR (Physician's Desk Reference) and meets the NCEP guidelines for first-line treatment of primary dyslipidemia.  It has also been studied as an adjunct to statins. Unicity continues to dedicate a large portion of the company budget to continued science and research. The most current ongoing study with Bios Life Slim is evaluating patients with metabolic syndrome in a controlled, double blind randomized trial with crossover arm at a prestigious US teaching hospital and university.

Click on the products to the left for more detailed information about each.

    

Clinicals

Cellular Essentials

Coronary artery trial by Dr. Niedzwiecki
Published in Nutritional Supplement Program Halts Progression of Early Coronary Atherosclerosis Documented by Ultrafast Computed Tomography Journal of Applied Nutrition 1996, 48: 67-78.
reprint

Carotid artery trial by Dr. Bill Curley
Presented at 7th Conference on Arteriosclerosis, Thrombosis and Vascular Biology, 2005, Washington, DC
abstract — poster

Cardio Essentials

Congestive Heart Failure trial by Dr. Jeejeebhoy

Published in Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction: Farida Jeejeebhoy, MD, Mary Keith, PhD, Michael Freeman, MD, Aiala Barr, PhD, Michele McCall, MSc, RD, Regina Kurian, BSc, David Mazer, MD, and Lee Errett, MD, Am Heart J 2002;143:1092-100. (the product MyoVive is marketed by our previous parent company and has the same ingredients as Cardio Essentials)
reprint

Omega Life-3

Currently, Omega Life 3 is being studied by Columbia University in New York City at the department of psychiatry to evaluate the effects on depression. More information will follow later.

Daily Produce 24

DP24 has been studied in relationship to its antioxidant potential. The study was presented at the 2004 Experimental Biology meeting by J.C. Young et al. with title “The Effect of Soluble Fiber on Glucose Tolerance and Antioxidant Status in Insulin-Resistance Rats”
abstract

VISUtein

VISUtein Study by Dr. David Newsome.
press release

CM Plex

CM Plex Softgels study by Dr. Hesslink.
Published in Effect of a Cetylated Fatty Acid Topical Cream on Functional Mobility and Quality of Life of Patients with Osteoarthritis William J. Kraemer, Nicholas A. Ratamess, Jeffrey M. Anderson, Carl M. Maresh, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Duncan N. French, Matthew J. Sharman, Martyn R. Rubin, Aan L. Gomez, Jeff S. Volek, and Robert L. Hesslink Jr., J Rheumatol 2004;31:767–74
reprint

CM Plex Cream study by Dr. Kraemer.
Published in Cetylated Fatty Acids Improve Knee Function in Patients with Osteoarthritis

Robert Hesslink Jr., David Armstrong III, M.V. Nagendran, Srinan Sreevatsan, and Raj Barathur J. Rheumatol 2002;29:1708-12.
reprint

Bios Life

Overview of all Bios Life clinical study results

Cleveland Clinic Trial by Dr. Dennis Sprecher
Published in Sprecher DL, Pearce GL (2002) Fiber-multivitamin combination therapy: a beneficial influence on lowdensity lipoprotein and homocysteine Metabolism 51, 1166-70.
reprint

Diabetes in Control Study #1 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2000) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes Diabetes in Control 12-8.
abstract

Diabetes in Control Study #2 by Steven Freed and David Joffe
Published in Freed S, Joffe D (2004) The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Diabetes II Diabetes in Control 212, 17, and Verdegem P, Freed S, Joffe D (2005) The clinical impact of fiber supplementation for the reduction of postprandial blood blucose and reduction of complications from type-2 diabetes Diabetes 54, A425.
abstract

Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation on Cardio-Vascular Risk Parameters in type-2 Diabetes in 6th International Conference on Atherosclerosis, Thrombosis and Vascular Biology. 2005. Washinton, DC, USA. The American Heart Association sent out a press release on the study results.
abstract — poster — AHA press release

Presented by Verdegem P, Freed S, Joffe D. The Clinical Impact of Fiber Supplementation for the Reduction of Postprandial Blood Glucose and Risk Reduction of Complications from Type-2 Diabetes. in 65th Scientific Session American Diabetes Association. 2005. San Diego, CA, USA.
poster

Philippines Trial by Dr. Yumul
Presented by Balajadia E, Valerio A, Yumul N. Beneficial effects of Bios Life 2 (Dietary Fiber Supplement) in patients with dyslipidemia. in 34th Annual Convention of the Philippine College of Physicians. 2004.
reprint

Utah Trial by Dr. Peter J.E. Verdegem
As published by Verdegem P (2007) Viscous soluble fiber combined with phytosterols and policosanol reduces LDL-c and increases HDL-c in hypercholesterolemia Current Topics in Neutraceutical Research.
reprint

Utah Trial #2 by Dr. Peter J.E. Verdegem
As presented by Verdegem P, Duenas V, Duenas J, Burke E. LDL- and HLD-cholesterol optimization using phytonutrient combination therapy: first line intervention and adjunct therapy to statins in 1st Asian Preventive Cardiology & Cardiac Rehabilitation Conference. 2006. Hong Kong.

Presented at the 7th International Congress on Coronary Artery Disease, 2007, Venice, Italy.
abstract

Pacific Rim Trial by Dr. Vincent Duenas
Published in Duenas V, Duenas J, Burke E, Verdegem P (2006) A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia Arterioscler Thromb Vasc Biol 26, e53-e107.
abstract

Presented by Duenas V, Duenas J, Burke E, Verdegem P. A new fiber drink can serve as an adjunct therapy to statin medication in mild hypercholesterolemia. in 7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2006. Denver.
abstract total user group — poster results total user group — poster results statin user group

Texas Trial by Dr. Isabel Martinez
Presented by Martinez I, Horne B, Verdegem P. Lipid and glucose optimization using phytonutrient combination therapy in diabetes. in 8th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. 2007. Chicago.
abstract

Income Disclaimer:  *Individual results may vary.  There are no guarantees.  Your results will be based solely on your own effort.